⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
EU and USA Veterinary Drug Development Training Course: Pharmaceutical, Pharmacological, Toxicological and Clinical Investigations and Regulatory Management (ONLINE EVENT: June 15th - June 18th, 2026)
globenewswire.com
MRK
VCTR
MilliporeSigma Launches 2026 Global Curiosity Cube(TM) Tour, Bringing STEM Learning to Students
accessnewswire.com
MRK
Mestag Therapeutics Selected to Present Targeted LTBR Agonist MST‑0312 in Late‑Breaking Session at AACR Annual Meeting
globenewswire.com
MRK
JNJ
Kelun-Biotech Announces Results from the SKB264-II-06/MK-2870-002 Study of Sacituzumab Tirumotecan (Sac-TMT) in Gynecologic Oncology Presented at 2026 SGO USA - English APAC - Traditional Chinese APAC - English
prnewswire.com
MRK
Florida Cancer Specialists & Research Institute Contributes to Milestone that Expands Treatment Options For Patients With Recurrent Ovarian Cancer
prnewswire.com
MRK
Francois Schramek Promoted to Partner at Manhattan West
prnewswire.com
AI
AMN
GM
LMT
NVDA
GOOG
MSFT
SPCE
RKLB
GD
BA
AMD
INTC
META
CRWD
PLTR
AN
DD
HON
RTX
IBM
AMZN
TSLA
XOM
CVX
UNH
BMY
PFE
MRK
JNJ
LLY
GILD
REGN
BIIB
AMGN
AZN
NVO
SNY
TEVA
BABA
JD
NTES
BIDU
IQ
VIPS
BZUN
HTHT
MELI
BBD
BB
ERIC
NOK
QCOM
MU
ADSK
CRM
GOOGL
1 Day 2024 EU AI Act Legislative Changes and Potential Impact on Healthcare Webinar: (ONLINE EVENT: June 23, 2026)
globenewswire.com
MRK
Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Based Chemotherapy
businesswire.com
MRK
Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Based Chemotherapy
businesswire.com
MRK
Cell Therapy Technology Market Research and Global Forecast Report 2025-2030: Rising Chronic Disease Burden and CRISPR-Driven Gene Editing Innovations Driving Growth
globenewswire.com
TMO
DHR
MRK